Inovio Pharmaceuticals Stock News

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) with the stream of -3.67% also noticed, India Altria Group, Inc. (NYSE:MO) encountered a rapid change of 1.12% in the last hour of Fridays trading session. The post Volatile Stock to Watch: Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Altria Group, Inc. (NYSE:MO) appeared first on Stocks Equity .

Brokerages expect Inovio Pharmaceuticals, Inc. (NASDAQ:INO) to report earnings per share of ($0.34) for the current fiscal quarter, according to Zacks. Four analysts have provided estimates for Inovio Pharmaceuticals earnings. The highest EPS estimate is ($0.28) and the lowest is ($0.37). Inovio Pharmaceuticals reported earnings of ($0.14) per share during the same quarter last year, []

Inovio Pharmaceuticals Inc. (NASDAQ:INO)s traded shares stood at 3.65 million during the last session, with the companys beta value hitting 0.59. At the close of trading, the stocks price was $6.64, to imply an increase of 1.68% or $0.11 in intraday trading. The INO shares 52-week high remains $19.00, putting it -186.14% down since that Inovio Pharmaceuticals Inc. (NASDAQ: INO): Can The Stock Still Lose Despite An -24.97% YTD Loss? Read More »

Shares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) have received an average recommendation of Hold from the eight ratings firms that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and two have assigned a buy recommendation to the company. The average []

Vaccines Market Key Players Studied in this Report Are GlaxoSmithKline plc. (Brentford, United Kingdom), Sanofi (Paris, France), Pfizer Inc. (New York, United States), Merck & Co., Inc. (New Jersey, United States), Novartis AG (Basel, Switzerland), Emergent BioSolutions, Inc. (Maryland, United States), CSL Limited (Melbourne, Australia), Inovio Pharmaceuticals, Inc. (Pennsylvania, United States), Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Osaka, Japan), Other Prominent Players. Vaccines Market Key Players Studied in this Report Are GlaxoSmithKline plc. (Brentford, United Kingdom), Sanofi (Paris, France), Pfizer Inc. (New York, United States), Merck & Co., Inc. (New Jersey, United States), Novartis AG (Basel, Switzerland), Emergent BioSolutions, Inc. (Maryland, United States), CSL Limited (Melbourne, Australia), Inovio Pharmaceuticals, Inc. (Pennsylvania, United States), Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Osaka, Japan), Other Prominent Players.

These second-tier COVID-19 vaccine players plunged due to fears about the potential impacts of the omicron variant.

This move is a reversal from the hour prior, which saw price move down. The post Inovio Pharmaceuticals Inc (INO): Price Now Near $6.67; Daily Chart Shows Downtrend on 100 Day Basis appeared first on ETF Daily News .

Morgan Stanley lifted its position in shares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) by 185.6% during the second quarter, Holdings Channel.com reports. The firm owned 830,060 shares of the biopharmaceutical companys stock after buying an additional 539,469 shares during the quarter. Morgan Stanleys holdings in Inovio Pharmaceuticals were worth $7,694,000 as of its most recent filing []

Inovio plans to tackle the omicron variant.

Inovio Pharmaceuticals, Inc. (INO) with the stream of 4.77% also noticed, India Teladoc Health, Inc. (TDOC) encountered a rapid change of 3.41% in the last hour of trading session. Inovio The post Highly Unusual Volume Spikes: Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Teladoc Health, Inc. (NYSE:TDOC) appeared first on Stocks Equity .

New Delhi: In South Africa, Omicron, a new corona infection subtype, has developed. It has sparked fear throughout the world. According to the information so far, the new variant is also capable of beating the corona vaccination. Many scientists have also warned that if new corona variations emerge, the vaccination would need to be modified as well. With the emergence of the omicron, efforts to develop a vaccine for it have accelerated. Novavax, a firm based in the United States, said that it has begun developing a vaccine to combat new strains. The vaccine will also be available for testing and manufacture in the coming weeks, according to the firm. The business claims to be developing a spike protein that would boost immunity against the new variety B.1.1.529. This week, a novel Corona B.1.1529 strain was discovered in South Africa. The World Health Organization (WHO) labelled it as "alarming" on Friday, using the term "variant of concern" to describe it. ''Omicron'' is the name given to it.

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) gapped up prior to trading on Friday . The stock had previously closed at $6.92, but opened at $7.21. Inovio Pharmaceuticals shares last traded at $7.51, with a volume of 22,376 shares changing hands. Several brokerages have recently weighed in on INO. Zacks Investment Research upgraded Inovio Pharmaceuticals from a sell []

Inovio Pharmaceuticals (NASDAQ:INO) and Assure (OTCMKTS:ARHH) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, analyst recommendations, institutional ownership, risk and valuation. Valuation & Earnings This table compares Inovio Pharmaceuticals and Assures top-line revenue, earnings per share (EPS) []

Both vaccine makers still have big hurdles to jump.

Catalysts for the stocks are just ahead.